Search For "pfizer biontech covid 19 vaccine"
US approves Pfizer, Moderna Covid-19 vaccines for youngest children
Updated : 3 years, 9 months ago IST
Washington [US], June 17 (ANI): The US Food and Drug Administration (FDA) authorized emergency use of the Moderna COVID-19 Vaccine and the Pfizer-BioNTech COVID-19 Vaccine for the prevention of COVID-19 to include use in children down to 6 months of age.
Read More
Three doses of COVID vaccine better than two? Study suggests so!
Updated : 4 years, 1 month ago IST
California [US], February 14 (ANI): The majority of the vaccines available for COVID-19 have two doses. People are said to become more capable of resisting the virus after the second dose. But, a recent Kaiser Permanente study, found that one month after a third dose, the effectiveness of th
Read More
Pfizer, BioNTech seek emergency authorization for COVID-19 vaccine for kid
Updated : 4 years, 1 month ago IST
New York [US], February 2 (ANI): The pharmaceutical companies, Pfizer and BioNTech, are seeking Emergency Use Authorization for their COVID-19 vaccine for use in children between six months and four years of age.
Read More
'Three doses of Pfizer-BioNTech COVID-19 vaccine neutralizes Omicron varia
Updated : 4 years, 3 months ago IST
New York [US]/Mainz [Germany], December 9 (ANI): A preliminary laboratory study demonstrated that three doses of the Pfizer-BioNTech COVID-19 vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers.
Read More
FDA advisors to rule on Pfizer vaccine in younger children as experts fore
Updated : 4 years, 5 months ago IST
Washington [US], October 26 (ANI/Xinhua): Advisors to the U.S. Food and Drug Administration (FDA) are set for a key meeting Tuesday on whether to recommend the Pfizer-BioNTech COVID-19 vaccine for children ages 5 to 11, as experts predicted younger kids will be eligible for the vaccine in e
Read More
US CDC panel endorses Pfizer booster shot for elderly, high-risk people
Updated : 4 years, 6 months ago IST
Washington [US], September 24 (ANI/Xinhua): A U.S. Centers for Disease Control and Prevention (CDC) advisory panel on Thursday endorsed booster doses of the Pfizer-BioNTech COVID-19 vaccine for Americans aged 65 and older and some adults with certain high risk conditions.
Read More
US: FDA gives full approval to Pfizer-BioNTech COVID 19 vaccine
Updated : 4 years, 7 months ago IST
Washington [US] August 23 (ANI): The US Food and Drug Administration (FDA) on Monday gave full approval to Pfizer's COVID-19 vaccine.
Read More
Pfizer and BioNTech announce submission of Initial data to US FDA to suppo
Updated : 4 years, 7 months ago IST
New York [US], August 17 (ANI): Pfizer and BioNTech announced that they have submitted Phase 1 data to the United States Food and Drug Administration (FDA) to support the evaluation of a third, or booster dose of the companies' COVID-19 vaccine for future licensure.
Read More
Covid-19: Pfizer says it is time for booster dose, US govt officials say n
Updated : 4 years, 8 months ago IST
Washington [US], July 9 (ANI): US drugmaker Pfizer and Germany's BioNTech have announced that they will seek regulatory authorisation for a third dose of their Covid-19 vaccine.
Read More
US to ship 500 million COVID vaccines from August
Updated : 4 years, 9 months ago IST
Washington [US], June 10 (ANI): The United States will ship the first batch of 500 million doses of Pfizer-BioNTech COVID-19 vaccines to 92 countries from the month of August, the White House announced on Thursday.
Read More
Discussions underway with GOI for supply of Pfizer-BioNTech COVID vaccine,
Updated : 4 years, 10 months ago IST
New Delhi [India], May 24 (ANI): To bring Pfizer-BioNTech COVID-19 vaccine for use in India, discussions are underway between the Government of India (GOI) and Pfizer Inc.
Read More
US CDC recommends Pfizer COVID-19 vaccine for 12-15 yrs old
Updated : 4 years, 10 months ago IST
Washington [US], May 13 (ANI): An advisory panel of the Centres for Disease Control and Prevention on Wednesday (local time) recommended the use of Pfizer-BioNTech COVID-19 vaccine for children aged between 12 and 15.
Read More